Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss

Clin Immunol. 2019 Jun:203:37-44. doi: 10.1016/j.clim.2019.04.005. Epub 2019 Apr 8.

Abstract

Recurrent pregnancy loss (RPL) is often considered idiopathic, however excessive complement activation has been observed in pregnancy related manifestations. Anti-C1q antibodies (anti-C1q) are associated with the activation of complement pathway in lupus patients, while it remains unclear in RPL. Firstly, we showed that both the prevalence and titre of anti-C1q were significantly higher in unexplained RPL than in healthy parous individuals. Secondly, we established the murine model of anti-C1q induced pregnancy loss using a monoclonal anti-mouse C1q antibody, JL-1. In mice treated with JL-1, high ratio of pregnancy loss and fetal growth restriction were frequently observed and complement activation occurred. C5a receptor (C5aR) blockade cancelled these pathogenic changes in mice treated with JL-1. In conclusion, our study reveals an association between the prevalence of anti-C1q and RPL. Additionally, our murine model has indicated that anti-C1q can induce reproductive failure, which might be ameliorated by therapy targeting the C5-C5aR axis.

Keywords: Anti-C1q autoantibody; Complement activation; Recurrent pregnancy loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Habitual / immunology*
  • Adult
  • Animals
  • Antibodies, Blocking / administration & dosage
  • Autoantibodies / administration & dosage
  • Autoantibodies / metabolism*
  • Complement C1q / immunology*
  • Complement C1q / metabolism
  • Complement C5 / metabolism*
  • Cross-Sectional Studies
  • Disease Models, Animal
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Receptor, Anaphylatoxin C5a / antagonists & inhibitors*
  • Retrospective Studies
  • Signal Transduction

Substances

  • Antibodies, Blocking
  • Autoantibodies
  • Complement C5
  • Receptor, Anaphylatoxin C5a
  • Complement C1q